You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CYCLOCORT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cyclocort, and when can generic versions of Cyclocort launch?

Cyclocort is a drug marketed by Astellas and is included in three NDAs.

The generic ingredient in CYCLOCORT is amcinonide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amcinonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cyclocort

A generic version of CYCLOCORT was approved as amcinonide by TARO PHARM INDS on May 31st, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CYCLOCORT?
  • What are the global sales for CYCLOCORT?
  • What is Average Wholesale Price for CYCLOCORT?
Summary for CYCLOCORT
US Patents:0
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 53
Patent Applications: 5,768
DailyMed Link:CYCLOCORT at DailyMed
Drug patent expirations by year for CYCLOCORT

US Patents and Regulatory Information for CYCLOCORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CYCLOCORT amcinonide OINTMENT;TOPICAL 018498-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CYCLOCORT amcinonide CREAM;TOPICAL 018116-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CYCLOCORT amcinonide LOTION;TOPICAL 019729-001 Jun 13, 1988 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CYCLOCORT

See the table below for patents covering CYCLOCORT around the world.

Country Patent Number Title Estimated Expiration
Netherlands 7410613 ⤷  Sign Up
Hong Kong 44778 NOVEL TRIAMCINOLONE DERIVATIVE ⤷  Sign Up
Ireland 39738 NOVEL TRIAMCINOLONE DERIVATIVE ⤷  Sign Up
France 2240738 ⤷  Sign Up
Belgium 818929 ⤷  Sign Up
Malaysia 7800234 NOVEL TRIAMCINOLONE DERIVATIVE ⤷  Sign Up
Israel 45200 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.